The U.S. Food and Drug Administration (FDA) recently approved sapropterin (Kuvan) for individuals with Phenylketonuria (PKU) — an inherited deficiency of the enzyme phenylalanine hydroxylase (PAH).
read the whole article here.
Subscribe to:
Post Comments (Atom)
Click to subscribe to PhilNurse
An Online group for & by Filipino
Nurses
No comments:
Post a Comment